Mirae Asset Global Etfs Holdings Ltd. Olema Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 25,492 shares of OLMA stock, worth $123,126. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,492
Previous 16,856
51.23%
Holding current value
$123,126
Previous $182,000
67.03%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding OLMA
# of Institutions
152Shares Held
60.3MCall Options Held
141KPut Options Held
23.1K-
Bvf Inc San Francisco, CA9.14MShares$44.1 Million3.47% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA7.47MShares$36.1 Million11.76% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.5MShares$26.6 Million2.37% of portfolio
-
Black Rock Inc. New York, NY4MShares$19.3 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.69MShares$17.8 Million0.12% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $195M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...